X-ray crystallography, molecular modeling, and site-directed mutagenes
is were used to delineate the catalytic mechanism of purine nucleoside
phosphorylase (PNP), PNP catalyzes the reversible phosphorolysis of p
urine nucleosides to the corresponding purine base and ribose 1-phosph
ate using a substrate-assisted catalytic mechanism, The proposed trans
ition state (TS) features an oxocarbenium ion that is stabilized by th
e cosubstrate phosphate dianion which itself functions as part of a ca
talytic triad (Glu89-His86-PO4=). Participation of phosphate in the TS
accounts for the poor hydrolytic activity of PNP and is likely to be
the mechanistic feature that differentiates phosphorylases from glycos
idases, The proposed PNP TS also entails a hydrogen bond between N7 an
d a highly conserved Asn. Hydrogen bond donation to N7 in the TS stabi
lizes the negative charge that accumulates on the purine ring during g
lycosidic bond cleavage, Kinetic studies using N7-modified analogs pro
vided additional support for the hydrogen bond. Crystallographic studi
es of 13 human PNP-ligand complexes indicated that PNP uses a ligand-i
nduced conformational change to position Asn243 and other key residues
in the active site for catalysis. These studies also indicated that p
urine nucleosides bind to PNP with a nonstandard glycosidic torsion an
gle (+anticlinal) and an uncommon sugar pucker (C4'-endo). Single poin
t energy calculations predicted the binding conformation to enhance ph
osphorolysis through ligand strain. Structural data also suggested tha
t purine binding precedes ribose 1-phosphate binding in the synthetic
direction whereas the order of substrate binding was less clear for ph
osphorolysis, Conservation of the catalytically important residues acr
oss nucleoside phosphorylases with specificity for 6-oxopurine nucleos
ides provided further support for the proposed catalytic mechanism.